Overview
Format
In person
Timing
7 AM - 4.30 PM EDT
September 15–17, 2026 | Charlotte Convention Center | Charlotte, NC | Booth #800
Celegence is proud to participate as an Innovator Sponsor at RAPS Convergence 2026, taking place September 15–17 at the Charlotte Convention Center in Charlotte, North Carolina.
Join regulatory professionals from around the world and connect with the Celegence team at Booth #800 to discuss evolving regulatory challenges, practical approaches to compliance, and how AI-enabled solutions combined with regulatory expertise can support more efficient regulatory operations.
Meet Us at RAPS Convergence 2026
Dates: September 15–17, 2026
Location: Charlotte Convention Center
501 S College St, Charlotte, NC 28202, USA
Celegence Booth: #800
Participation: Innovator Sponsor
Event Website: RAPS US Convergence 2026
Registration: Register here
Whether you are managing complex Pharmaceutical, Medical Device, and In-Vitro Diagnostics regulatory requirements, looking to improve regulatory processes, or exploring practical applications of AI in regulatory affairs, our team will be available throughout the event to discuss your priorities.
Planning to attend? Book a meeting with our team during RAPS Convergence 2026.
Featured Session :
Can AI Actually Write a Defensible State of the Art? Lessons from Building AI for Regulatory Evidence Synthesis
Wednesday, September 16 | 11:55 AM–12:20 PM
Exhibit Hall – Spark! Theater, Booth #1100
Speaker:
Anushree Singh, Business Development Manager, Celegence
Generative AI has demonstrated impressive capabilities in summarizing literature and drafting content. But producing a regulatory-defensible State of the Art (SOTA) section for a Clinical Evaluation Report (CER) presents a very different challenge.
The process extends far beyond summarization. Evidence selection, duplication across hundreds of publications, traceability, synthesis, expert judgment, and the need to balance standardization with flexibility all influence whether the resulting content can withstand regulatory scrutiny.
In this session, Anushree Singh will share real-world lessons from developing AI-assisted approaches to regulatory evidence synthesis and explore where AI can provide meaningful efficiencies, where human regulatory expertise remains essential, and what a realistic AI-assisted SOTA workflow could look like.
What Attendees Will Learn
Upon completion of the session, participants should be able to:
- Identify the challenges of AI-generated SOTA content – Understand the technical and regulatory complexities that make SOTA development more demanding than literature summarization, including evidence duplication, traceability, and synthesis.
- Evaluate AI output for regulatory defensibility – Look beyond fluent or complete-looking content and assess whether AI-assisted SOTA drafting meets the standards expected of defensible regulatory evidence.
- Understand where AI and human expertise fit – Explore a realistic division of labor between AI-assisted drafting and expert regulatory judgment in future SOTA development workflows.
Meet the Celegence Team in Charlotte
Connect with our regulatory and business leaders throughout RAPS Convergence 2026:
- Lakshmeenarayana Goundalkar (LGG) – Chief Delivery Officer, Regulatory Services
- Sonia Veluchamy – CEO
- Punya Abbhi – COO
- Cheryl Jessen – Chief Revenue Officer
- Meghan Mahoney – Director, Business Development
Our team will be available to discuss regulatory strategy, medical device and IVD compliance, clinical evaluation, post-market requirements, regulatory operations, and opportunities to apply AI responsibly across regulatory workflows.
Regulatory Expertise, Accelerated by AI
As regulatory requirements continue to evolve, organizations need more than technology alone. Effective regulatory transformation requires the right combination of domain expertise, well-designed processes, and technology that supports, not replaces, expert judgment.
At RAPS Convergence 2026, we look forward to sharing how Celegence is combining regulatory expertise with AI-enabled technology to help life sciences organizations improve efficiency while maintaining quality, traceability, and regulatory rigor.
If you are attending the conference, stop by Booth #800 or schedule time with our team in advance.
If you would like to schedule a meeting or connect with our team during the event, reach out to us at info@celegence.com. We look forward to connecting with you in Charlotte.